Effect of adenosine 5´-triphosphate (ATP) challenge vs. adenosine 5´-monophosphate (AMP) on the threshold of capsaicin-induced cough in healthy non-smokers, current smokers and patients with asthma Source: Eur Respir J 2004; 24: Suppl. 48, 708s Year: 2004
Direct and indirect bronchial challenge tests with Methacholine and Adenosine monophosphate in asthmatic patients and healthy subjects Source: Annual Congress 2010 - Advances in lung function II Year: 2010
Post-exercise changes in FEV1 values and in adenosine concentrations in exhaled-breath condensate in healthy subjects and patients with exercise-induced asthma Source: Eur Respir J 2002; 20: Suppl. 38, 290s Year: 2002
Comparison of breath VOCs collected from controls, healthy smokers, smokers with COPD, and ex-smokers with COPD at two sites Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015
Quallity of life and bronhical hyperreactivity in healthy smokers Source: Eur Respir J 2003; 22: Suppl. 45, 305s Year: 2003
Adenosine 5' – triphosphate (ATP) and adenosine 5' – monophosphate (AMP) challenge testing in healthy non-smokers and patients with mild asthma Source: Eur Respir J 2003; 22: Suppl. 45, 350s Year: 2003
Cytokine expression in induced sputum in smokers with asthma or COPD and in healthy smokers Source: Eur Respir J 2003; 22: Suppl. 45, 392s Year: 2003
Measurement of adenosine in exhaled breath condensate in healthy volunteers and patients with asthma Source: Eur Respir J 2002; 20: Suppl. 38, 423s Year: 2002
Bronchoconstriction induced by inhaled adenosine 5'-monophosphate in subjects with allergic rhinitis Source: Eur Respir J 2001; 17: 64-70 Year: 2001
Differences in responsiveness of airways to AMP and methacholine in asthma and COPD Source: Eur Respir J 2001; 18: Suppl. 33, 93s Year: 2001
Lung deposition of carmoterol in healthy subjects, patients with asthma and patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 211s Year: 2006
Asthma control is worse in asthmatic smokers compared to non-smokers with similar lung function Source: Annual Congress 2006 - New investigational approaches to smoking and smoking cessation Year: 2006
Biomarker reproducibility study in exhaled breath and induced sputum in nonsmokers, smokers and COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 77s Year: 2003
Exhaled adenosine triphosphate (ATP) concentration is elevated in stable asthmatic patients compared to control subjects Source: Annual Congress 2009 - Airway inflammation and asthma control Year: 2009
Adenosine 5’-triphosphate (ATP) is increased in exhaled breath condensate of children with asthma Source: Eur Respir J 2004; 24: Suppl. 48, 688s Year: 2004
The bronchoprotective effects of levocetirizine on adenosine monophosphate challenge in patients with atopic asthma Source: Eur Respir J 2004; 24: Suppl. 48, 220s Year: 2004
Adenosine receptor expression in sputum of COPD and asymptomatic smokers, before and one year after smoking cessation Source: Eur Respir J 2007; 30: Suppl. 51, 213s Year: 2007
Allergic rhinitis is associated with elevated adenosine level in exhaled breath condensate in nonasthmatic patients Source: Annual Congress 2003 - Developments and applications with exhaled breath condensate and exhaled air Year: 2003
Lung deposition of formoterol HFA in healthy volunteers, asthmatic and COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 314s Year: 2005
Adenosine 5’ – triphosphate (ATP) and adenosine 5' – monophosphate (AMP) challenge testing in current smokers and patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2003; 22: Suppl. 45, 414s Year: 2003